Ipamorelin + CJC-1295 Stack
Ipamorelin and CJC-1295 Combination
The most popular growth hormone peptide stack combining a GHRP (Ipamorelin) with a GHRH (CJC-1295) for synergistic GH release.
Typical Cost
$150-300/month combined
Status
Research
Peptide Profile
Ipamorelin + CJC-1295 Stack
Mechanism of Action
Ipamorelin stimulates ghrelin receptors triggering GH pulses. CJC-1295 amplifies GHRH signaling. Together they produce greater GH elevation than either alone through synergistic mechanisms.
Common Dosages
subcutaneous
Ipamorelin 100-300mcg + CJC-1295 100-300mcg
Daily or 5x weekly · 12-16 weeks
Benefits
Synergistic GH elevation
Better than either alone
Fat loss
Muscle preservation
Improved recovery
Better sleep
Side Effects
Water retention
Numbness/tingling
Increased hunger
Injection site reactions
Key Research
GHRP + GHRH synergy
Combined use produces greater GH elevation than single agents
Regulatory Status
Research chemicals only. Not FDA-approved. Popular in anti-aging and fitness communities.
Contraindications
- ⚠Active cancer
- ⚠Diabetic retinopathy
- ⚠Pregnancy/breastfeeding
GLP-1 users focused on body composition may consider this stack alongside SeraVia Muscle+ Protect.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.